Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Watkins, Louise F.

  • Google
  • 1
  • 10
  • 0

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2022Resistance to Ceftriaxone and Ciprofloxacin in Nontyphoidal <i>Salmonella</i> from Humans and Relatedness to Isolates from Animal Sourcescitations

Places of action

Chart of shared publication
Leeper, Molly M.
1 / 1 shared
Sayeed, Sameera
1 / 1 shared
Mikanatha, Nkuchia M.
1 / 2 shared
Boktor, Sameh
1 / 1 shared
Folster, Jason P.
1 / 1 shared
Dudley, Edward G.
1 / 2 shared
Hackman, Nicole M.
1 / 1 shared
Dettinger, Lisa
1 / 1 shared
Tate, Heather
1 / 1 shared
Thirumalapur, Nagaraja
1 / 1 shared
Chart of publication period
2022

Co-Authors (by relevance)

  • Leeper, Molly M.
  • Sayeed, Sameera
  • Mikanatha, Nkuchia M.
  • Boktor, Sameh
  • Folster, Jason P.
  • Dudley, Edward G.
  • Hackman, Nicole M.
  • Dettinger, Lisa
  • Tate, Heather
  • Thirumalapur, Nagaraja
OrganizationsLocationPeople

article

Resistance to Ceftriaxone and Ciprofloxacin in Nontyphoidal <i>Salmonella</i> from Humans and Relatedness to Isolates from Animal Sources

  • Leeper, Molly M.
  • Sayeed, Sameera
  • Mikanatha, Nkuchia M.
  • Watkins, Louise F.
  • Boktor, Sameh
  • Folster, Jason P.
  • Dudley, Edward G.
  • Hackman, Nicole M.
  • Dettinger, Lisa
  • Tate, Heather
  • Thirumalapur, Nagaraja
Abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Nontyphoidal Salmonella (NTS) is a leading cause of foodborne bacterial infections. Annually, ∼200,000 antimicrobial-resistant (AMR) NTS illnesses occur in the United States. NTS infections resistant to ceftriaxone and ciprofloxacin, drugs used for the treatment of severe infections, are a growing concern.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We identified patient NTS isolates submitted to the Pennsylvania Bureau of Laboratories by two hospitals from the same health system during 2018–2020. All were tested by broth microdilution for susceptibility to antibiotics tracked by the National Antimicrobial Resistance Monitoring System and analyzed by whole-genome sequencing. We identified resistance mechanisms and plasmids with ResFinder and PlasmidFinder, respectively, and compared each isolate in selected serotypes against the PulseNet database to identify genetic relatedness within ≤5 allele differences to non-human sequences uploaded during 2017–2021.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 164 human NTS analyzed for susceptibility, 28 (17%) had decreased susceptibility to ciprofloxacin (DSC) [MIC ≥0.12 µg/mL] while 6 (3.7%) were ceftriaxone-resistant. AMR varied by serotype; 8 (50%) S. Infantis and 16 (42%) Enteritidis had DSC, representing 86% of all isolates with DSC (Figure). Six ceftriaxone-resistant isolates had genes that confer resistance to third-generation cephalosporins including blaCMY−2 in 1 Dublin and 2 Typhimurium and blaCTX-M-65 in 3 Infantis isolates. The 3 Infantis isolates also had a mutation in gyrA that results in DSC, plus a known transmissible plasmid IncFIB(pN55391) linked to multiple resistance genes. An Infantis isolate was related to a chicken meat isolate and a Hadar isolate was related to isolates from 3 animals and 3 meat sources. One Dublin isolate was related to 2 isolates from beef in Pennsylvania. Figure.Percent of antimicrobial resistance in nontyphoidal Salmonella (NTS) clinical isolates (n=164) submitted to public health authorities by two hospital systems in Pennsylvania, 2018–2020. Multidrug resistance (MDR) was defined as resistance to ≥3 of the 9 antimicrobial classes tested for NTS clinical isolates. Resistance to ceftriaxone (AXO), a third-generation cephalosporin preferred for treating severe infections in children, was over 5% and 19% in serotypes S. Typhimurium and S. Infantis, respectively. Half (8/16) of Infantis isolates and 42% (16/38) of Enteritidis isolates had decreased susceptibility to ciprofloxacin (DSC).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Ceftriaxone resistance and DSC in NTS from patients in Pennsylvania varied by serotype and some isolates harbored blaCMY−2 and blaCTX-M-65 genes. Dissemination of mechanisms that confer resistance to ceftriaxone and DSC is concerning as is the genetic relatedness of isolates from human and animal sources. Our study highlights the need for enhanced One Health AMR monitoring combined with a review of animal production and food processing practices.</jats:p></jats:sec><jats:sec><jats:title>Disclosures</jats:title><jats:p>All Authors: No reported disclosures.</jats:p></jats:sec>

Topics
  • impedance spectroscopy
  • differential scanning calorimetry
  • size-exclusion chromatography
  • susceptibility